Columbia University bioethicist Maya Sabatello says a Truth and Reconciliation Commission is needed to confront the structural racism in health care (and society) highlighted by the COVID-19 pandemic.
Cancer patients are especially vulnerable to COVID and would benefit from the protection the vaccine offers, says Gary Schwartz, MD, deputy director of the Herbert Irving Comprehensive Cancer Center.
A strategic decision-making and team-building exercise for hospital executives—developed at Columbia University Mailman School of Public Health—now includes a simulated pandemic.
Viral load, the amount of virus detected in a PCR nasal swab, can be used to predict patient outcomes and guide quarantine decisions, Daniel Griffin says.
Magdalena Sobieszczyk, MD, chief of the division of infectious diseases at Columbia, explains how COVID-19 vaccine candidates work and their role in fighting the pandemic.
Community health workers at NYP/CUIMC were needed more than ever during the pandemic, helping patients access the resources they needed to stay healthy and safe.
The CUIMC Newsroom spoke with epidemiologist Dr. Sandra Albrecht about how to vote and celebrate the holidays this year while practicing good public health and staying safe from COVID.
Coronaviruses are adept at mimicking human immune proteins called complement, which may allow the viruses to gain a foothold in our bodies and cause disease.
Columbia/NYSPI researchers are examining how millions of college students are addressing COVID-19 challenges, including academic/life plans, decision-making, substance use, and mental well-being.
For mental health professionals, teletherapy can feel like it’s “one step removed,” although studies suggest it produces outcomes statistically equivalent to face-to-face treatment.
New data from Columbia and other ECMO centers throughout the world show that more than 60% of severe COVID-19 patients who receive ECMO, a heart-lung life support machine, survive.
Outbreaks of SARS-CoV-2 may become a regular occurrence depending on the risk of reinfection, vaccine availability and efficacy, and interactions with other viruses, Mailman researchers say.